Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



DAWES KAREN A Create: Alert

All | News | Filings
Date FiledTypeDescription
05/22/2023 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Granted 798 shares @ $0
Granted 1,730 options to buy @ $156.63, valued at $271k
09/09/2022 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 775 shares @ $227.17, valued at $176.1k
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2021 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 462 shares @ $259.75, valued at $120k
Sold 236 shares @ $261.1, valued at $61.6k
Sold 1,038 shares @ $262.28, valued at $272.2k
Sold 1,119 shares @ $263.23, valued at $294.6k
Sold 336 shares @ $264.21, valued at $88.8k
Sold 488 shares @ $265.27, valued at $129.5k
Sold 486 shares @ $266.72, valued at $129.6k
Sold 349 shares @ $267.75, valued at $93.4k
Sold 255 shares @ $269.94, valued at $68.8k
Sold 14 shares @ $271.28, valued at $3.8k
Exercised 4,783 options to buy @ $26.12, valued at $124.9k
11/04/2021 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 64 shares @ $299.02, valued at $19.1k
Sold 251 shares @ $301.2, valued at $75.6k
Sold 446 shares @ $301.97, valued at $134.7k
Sold 532 shares @ $303.48, valued at $161.5k
Sold 124 shares @ $304.23, valued at $37.7k
Sold 700 shares @ $305.91, valued at $214.1k
Sold 283 shares @ $306.49, valued at $86.7k
09/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2021 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 288 shares @ $200.01, valued at $57.6k
Sold 806 shares @ $201.37, valued at $162.3k
Sold 2,877 shares @ $202.29, valued at $582k
Sold 614 shares @ $203.11, valued at $124.7k
07/15/2021 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 1,520 shares @ $202.23, valued at $307.4k
Exercised 2,929 options to buy @ $41.19, valued at $120.6k
05/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2021 4 DAWES KAREN A (Director) has filed a Form 4 on Vaccitech plc
Txns: Bought 1,700 shares @ $17, valued at $28.9k
05/04/2021 4 DAWES KAREN A (Director) has filed a Form 4 on Vaccitech plc
Txns: Granted 34,328 options to buy @ $17, valued at $583.6k
06/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2020 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 10 shares @ $135.91, valued at $1.4k
Sold 43 shares @ $136.98, valued at $5.9k
Sold 282 shares @ $139.4, valued at $39.3k
Sold 182 shares @ $140.29, valued at $25.5k
05/19/2020 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Granted 722 shares @ $0
Sold 712 shares @ $135.76, valued at $96.7k
Sold 160 shares @ $136.92, valued at $21.9k
Sold 269 shares @ $138.6, valued at $37.3k
Sold 122 shares @ $139.32, valued at $17k
Sold 180 shares @ $140.62, valued at $25.3k
Sold 77 shares @ $141.45, valued at $10.9k
Sold 80 shares @ $142.45, valued at $11.4k
Granted 1,761 options to buy @ $128.18, valued at $225.7k
05/11/2020 4 DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc
Txns: Sold 15,834 shares @ $0.7914, valued at $12.5k
04/22/2020 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 3,202 shares @ $104.98, valued at $336.1k
Sold 8,998 shares @ $104.42, valued at $939.6k
Exercised 8,200 options to buy @ $3.3, valued at $27.1k
Exercised 11,800 options to buy @ $3.3, valued at $38.9k
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/19/2019 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 1,295 shares @ $77.35, valued at $100.2k
Exercised 20,000 options to buy @ $4.96, valued at $99.2k
06/14/2019 4 DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc
Txns: Sold 12,500 shares @ $3.1835, valued at $39.8k
05/17/2019 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Granted 1,292 shares @ $0
Granted 2,953 options to buy @ $67.71, valued at $199.9k
05/09/2019 4 DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc
Txns: Granted 39,584 shares @ $0
Exercised 31,250 restricted stock units @ $0
12/04/2018 4 DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc
Txns: Sold 8,421 shares @ $4.8361, valued at $40.7k
Exercised 15,000 options @ $1.49, valued at $22.4k
05/17/2018 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Granted 2,080 shares @ $0
Granted 4,626 options to buy @ $42.07, valued at $194.6k
05/15/2018 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Sold 20,000 shares @ $41.7968, valued at $835.9k
Exercised 20,000 options to buy @ $5.08, valued at $101.6k
05/10/2018 4 DAWES KAREN A (Director) has filed a Form 4 on DEPOMED INC
Txns: Granted 31,250 options to buy @ $0
08/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2016 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Granted 20,000 shares @ $0
06/28/2016 4 DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP
Txns: Paid exercise price by delivering 1,982 shares @ $23.46, valued at $46.5k
Exercised 15,000 options to buy @ $3.1, valued at $46.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy